Acadia Healthcare Company, Inc. (ACHC)
NASDAQ: ACHC · Real-Time Price · USD
30.12
0.00 (0.00%)
At close: Mar 28, 2025, 4:00 PM
29.68
-0.44 (-1.47%)
After-hours: Mar 28, 2025, 7:56 PM EDT
Acadia Healthcare Company Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Acadia Healthcare Company stock have an average target of 56.5, with a low estimate of 35 and a high estimate of 91. The average target predicts an increase of 87.58% from the current stock price of 30.12.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Acadia Healthcare Company stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 4 | 4 | 4 |
| Buy | 3 | 3 | 3 | 3 | 2 | 2 |
| Hold | 4 | 4 | 3 | 2 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Hold Maintains $48 → $37 | Hold | Maintains | $48 → $37 | +22.84% | Mar 25, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $64 → $43 | Buy | Maintains | $64 → $43 | +42.76% | Mar 3, 2025 |
| Keybanc | Keybanc | Buy Maintains $70 → $65 | Buy | Maintains | $70 → $65 | +115.80% | Mar 3, 2025 |
| Barclays | Barclays | Buy → Hold Downgrades $43 → $35 | Buy → Hold | Downgrades | $43 → $35 | +16.20% | Feb 28, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $50 → $45 | Strong Buy | Maintains | $50 → $45 | +47.74% | Feb 28, 2025 |
Financial Forecast
Revenue This Year
3.43B
from 3.15B
Increased by 8.78%
Revenue Next Year
3.75B
from 3.43B
Increased by 9.18%
EPS This Year
3.42
from 2.78
Increased by 23.05%
EPS Next Year
3.88
from 3.42
Increased by 13.50%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.6B | 4.0B | 4.4B | ||
| Avg | 3.4B | 3.7B | 4.0B | ||
| Low | 3.3B | 3.5B | 3.7B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 14.1% | 16.1% | 16.9% | ||
| Avg | 8.8% | 9.2% | 7.6% | ||
| Low | 3.3% | 2.4% | -1.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.92 | 4.36 | 4.89 | ||
| Avg | 3.42 | 3.88 | 4.75 | ||
| Low | 2.95 | 3.20 | 4.57 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 40.9% | 27.4% | 26.0% | ||
| Avg | 23.0% | 13.5% | 22.4% | ||
| Low | 6.1% | -6.3% | 17.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.